Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.  ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. 

Faculty Disclosures

Russell Smith, MD, FACS, Course Chair - Nothing to disclose
Bruce Haughey, MD, FACS - Nothing to disclose
Arjun Joshi, MD, FACS - Nothing to disclose
Merry Sebelik, MD, FACS - Nothing to disclose
David Shonka, MD, FACS - Nothing to disclose

Institutional Staff Disclosures

Danielle Julian, MS - Nothing to disclose
Babs Morrissiey, BS - Nothing to disclose
Cassin Morocco, BS - Nothing to disclose

Planning Committee Disclosures

Reid Adams MD, FACS - Nothing to disclosure
Anthony Anagnostou MD, FACS - Nothing to disclosure
Scott  Dulchavsky, MD, FACS - Nothing to disclosure
Paula Ferrada, MD, FACS - Nothing to disclosure
Richard Fine, MD, FACS - Nothing to disclosure
Heidi Frankel, MD, FACS - Nothing to disclosure
William Fry, MD, FACS - Nothing to disclosure
Ellen Hagopian MD, FACS - Nothing to disclosure
Marcus Jarboe, MD, FACS - Nothing to disclosure
Laura Johnson, MD, FACS - Nothing to disclosure
Lawrence Kim, MD, FACS - Nothing to disclosure 
Andrew  Kirkpatrick, MD, FACS - Acelity Corp. Unrestricted Support for an RCT to my Institution, PI of RCT; Innovative Trauma Care Corp., Travel and Lodging, Research and Presentation at Conference; SAM Medical, Travel and Lodging, Research and Presentation at Conference
Junji Machi, MD, FACS - Nothing to disclosure
Barbra S. Miller, MD, FACS - Nothing to disclosure
Lisa A. Orloff, MD, FACS - Nothing to disclosure
Grace S. Rozycki, MD, FACS - Nothing to disclosure
Stefan Scholz, MD, FACS - Nothing to disclosure
Amy Sisley, MD, FACS - Nothing to disclosure
R. Stephen Smith, MD, FACS - Nothing to disclosure
Russell B. Smith, MD, FACS - Nothing to disclosure
R. Eugene Zierler, MD, FACS - Nothing to disclosure
Nick Zyromski, MD, FACS- Nothing to disclosure